Hertzberg, M., Gandhi, M. K., Trotman, J., Butcher, B., Taper, J., Johnston, A., Gill, D., Ho, S.-J., Cull, G., Fay, K., Chong, G., Grigg, A., Lewis, I. D., Milliken, S., Renwick, W., Hahn, U., Filshie, R., Kannourakis, G., Watson, A.-M., Warburton, P., Wirth, A., Seymour, J. F., Hofman, M. S. and Hicks, R. J. (2017) “Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14”, Haematologica. Pavia, Italy, 102(2), pp. 356-363. doi: 10.3324/haematol.2016.154039.